...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Evacetrapib fails

Evacetrapib failed 1 1/2 years ago. However, the NEJM article just came out. Merck's anacetrapib/REVEAL study is the one we are waiting for.

Lilly news release on discontinuing the development of Evacetrapib from October 2015

A lesson on futility analyses from the CETP inhibitors

Share
New Message
Please login to post a reply